| Model Number |
BXA067902A |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
Obstruction/Occlusion (2422)
|
| Date of Event |
04/19/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
On (b)(6) 2020 the patient underwent endovascular treatment of a thoracoabdominal aortic aneurysm using gore® excluder® thoracoabdominal branch endoprostheses (tambe) in the aaa1701 tambe pivotal study.On (b)(6) 2021 occlusion was observed in the gore® viabahn® vbx balloon expandable endoprosthesis used as a bridging stent in the patient's right renal artery.It was reported that the occlusion was suspected to be related to the sharp angle that the device takes as it bridges from the tambe device.Reportedly the patient had a decline in renal function but does not require hemodialysis.It was reported that the event is ongoing.No treatment has been performed or is planned for the future.There were no further reported issues and there were no reported issues with any other implanted devices.
|
| |
|
Additional Manufacturer Narrative
|
|
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Due to no device return, an investigation could not be performed.A review of the manufacturing records indicated the lot met pre-release manufacturing specifications.
|
| |
|
Search Alerts/Recalls
|